Skip to main content

Table 1 Clinical details

From: Identification of the prognostic value of Th1/Th2 ratio and a novel prognostic signature in basal-like breast cancer

 

High Th1/Th2 ratio

Low Th1/Th2 ratio

p

n

125

89

 

Age (median [IQR]) *

55.00 [48.00, 64.00]

51.00 [46.00, 62.00]

0.105

Stage (%) *

 Stage I/II

106 (84.8)

64 (71.9)

0.365

 Stage III/IV

18 (14.4)

20 (22.5)

 Stage X

1 (0.8)

5 (5.6)

 

Histological type (%) *

 Infiltrating Ductal Carcinoma

106 (84.8)

74 (83.1)

0.398

 Infiltrating Lobular Carcinoma

7 (5.6)

0 (0.0)

 

 Other

12 (9.6)

15 (16.9)

Menopause status (%)

 Pre

39 (31.2)

30 (33.7)

0.535

 Post

79 (63.2)

51 (57.3)

 Unclear

7 (5.6)

8 (9.0)

 
  1. * Data of age didn’t fit the normal distribution, and the p value was calculated by non-norm method; p value of data of stage and histological type were calculated by Fisher’s Exact Test